Tags

Type your tag names separated by a space and hit enter

Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice.
Clin Transplant. 2019 09; 33(9):e13563.CT

Abstract

These updated guidelines of the AST IDCOP review vaccination of solid organ transplant candidates and recipients. General principles of vaccination as well as the use of specific vaccines in this population are discussed. Vaccination should be reviewed in the pre-transplant setting and appropriate vaccines updated. Both inactivated and live vaccines can be given pre-transplant. The timing of vaccination post-transplant should be taken into account. In the post-transplant setting, inactivated vaccines can be administered starting at 3 months post-transplant with the exception of influenza which can be given as early as one month. Inactivated vaccines can be safely administered post-transplant. There is accumulating data that live-attenuated vaccines can also be given to select post-transplant patients. Close contacts of transplant patients can receive most routine live vaccines. Specific vaccines including pneumococcal, influenza, hepatitis B, HPV, and meningococcal vaccines are discussed. Newer vaccines for seasonal influenza vaccine and herpes zoster are highlighted. Live-attenuated vaccines such as measles, mumps, rubella, and varicella are also discussed. Emerging data on live-attenuated vaccines post-transplant are highlighted.

Authors+Show Affiliations

Pediatric Infectious Diseases, Cincinnati Children's Hospital Medical Center & University of Cincinnati, Cincinnati, Ohio.Transplant Infectious Diseases, University Health Network, Toronto, Ontario, Canada.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31002409

Citation

Danziger-Isakov, Lara, et al. "Vaccination of Solid Organ Transplant Candidates and Recipients: Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice." Clinical Transplantation, vol. 33, no. 9, 2019, pp. e13563.
Danziger-Isakov L, Kumar D, AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13563.
Danziger-Isakov, L., & Kumar, D. (2019). Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clinical Transplantation, 33(9), e13563. https://doi.org/10.1111/ctr.13563
Danziger-Isakov L, Kumar D, AST ID Community of Practice. Vaccination of Solid Organ Transplant Candidates and Recipients: Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13563. PubMed PMID: 31002409.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. AU - Danziger-Isakov,Lara, AU - Kumar,Deepali, AU - ,, Y1 - 2019/06/05/ PY - 2019/04/07/received PY - 2019/04/11/accepted PY - 2019/4/20/pubmed PY - 2020/10/2/medline PY - 2019/4/20/entrez KW - immunogenicity KW - infection and KW - infection and infectious agents KW - infectious agents KW - meningococcal KW - pneumococcal KW - vaccine KW - viral: hepatitis B KW - viral: herpes zoster/Varicella KW - viral: influenza KW - viral: papillomavirus SP - e13563 EP - e13563 JF - Clinical transplantation JO - Clin Transplant VL - 33 IS - 9 N2 - These updated guidelines of the AST IDCOP review vaccination of solid organ transplant candidates and recipients. General principles of vaccination as well as the use of specific vaccines in this population are discussed. Vaccination should be reviewed in the pre-transplant setting and appropriate vaccines updated. Both inactivated and live vaccines can be given pre-transplant. The timing of vaccination post-transplant should be taken into account. In the post-transplant setting, inactivated vaccines can be administered starting at 3 months post-transplant with the exception of influenza which can be given as early as one month. Inactivated vaccines can be safely administered post-transplant. There is accumulating data that live-attenuated vaccines can also be given to select post-transplant patients. Close contacts of transplant patients can receive most routine live vaccines. Specific vaccines including pneumococcal, influenza, hepatitis B, HPV, and meningococcal vaccines are discussed. Newer vaccines for seasonal influenza vaccine and herpes zoster are highlighted. Live-attenuated vaccines such as measles, mumps, rubella, and varicella are also discussed. Emerging data on live-attenuated vaccines post-transplant are highlighted. SN - 1399-0012 UR - https://www.unboundmedicine.com/medline/citation/31002409/Vaccination_of_solid_organ_transplant_candidates_and_recipients:_Guidelines_from_the_American_society_of_transplantation_infectious_diseases_community_of_practice_ L2 - https://doi.org/10.1111/ctr.13563 DB - PRIME DP - Unbound Medicine ER -